Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986;21(Suppl 2):123S–128S. doi: 10.1111/j.1365-2125.1986.tb02861.x

Salt and hypertension

G A MacGregor
PMCID: PMC1400733  PMID: 3530296

Abstract

1 Studies comparing different communities have suggested that the amount of salt in the diet may play an important role in determining blood pressure levels within a particular community. Intervention studies have also suggested that salt intake may play an important role in determining blood pressure levels in man.

2 In animals, where more clearcut experiments can be done, an increase in salt intake both in inherited forms of hypertension and experimental hypertension causes a further rise in blood pressure. Recent work has suggested that this rise in blood pressure could be related to an inherited or imposed defect in the kidney's ability to excrete sodium, which will give rise to greater compensatory mechanisms to overcome the sodium retention. These compensatory mechanisms might eventually be responsible for the development of high blood pressure.

3 In patients who have already developed high blood pressure, restricting the amount of salt in the diet does cause a fall in blood pressure in many patients. However, short-term reduction of salt intake in normotensive subjects causes little, if any, fall in blood pressure. The effectiveness of short term salt restriction in lowering blood pressure in adults therefore appears to be related to the severity of the high blood pressure and, probably more directly, to the suppression of the renin system that occurs as blood pressure rises.

Keywords: salt, high blood pressure

Full text

PDF
123S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoki K., Yamori Y., Ooshima A., Okamoto K. Effects of high or low sodium intake in spontaneously hypertensive rats. Jpn Circ J. 1972 Jun;36(6):539–545. doi: 10.1253/jcj.36.539. [DOI] [PubMed] [Google Scholar]
  2. BALL C. O., MENEELY G. R. Observations on dietary sodium chloride. J Am Diet Assoc. 1957 Apr;33(4):366–370. [PubMed] [Google Scholar]
  3. Beard T. C., Cooke H. M., Gray W. R., Barge R. Randomised controlled trial of a no-added-sodium diet for mild hypertension. Lancet. 1982 Aug 28;2(8296):455–458. doi: 10.1016/s0140-6736(82)90491-3. [DOI] [PubMed] [Google Scholar]
  4. Blaustein M. P. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am J Physiol. 1977 May;232(5):C165–C173. doi: 10.1152/ajpcell.1977.232.5.C165. [DOI] [PubMed] [Google Scholar]
  5. Cappuccio F. P., Markandu N. D., Sagnella G. A., MacGregor G. A. Sodium restriction lowers high blood pressure through a decreased response of the renin system--direct evidence using saralasin. J Hypertens. 1985 Jun;3(3):243–247. doi: 10.1097/00004872-198506000-00008. [DOI] [PubMed] [Google Scholar]
  6. Curtis J. J., Luke R. G., Dustan H. P., Kashgarian M., Whelchel J. D., Jones P., Diethelm A. G. Remission of essential hypertension after renal transplantation. N Engl J Med. 1983 Oct 27;309(17):1009–1015. doi: 10.1056/NEJM198310273091702. [DOI] [PubMed] [Google Scholar]
  7. Dahl L. K., Heine M. Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ Res. 1975 Jun;36(6):692–696. doi: 10.1161/01.res.36.6.692. [DOI] [PubMed] [Google Scholar]
  8. Devynck M. A., Pernollet M. G., Rosenfeld J. B., Meyer P. Measurement of digitalis-like compound in plasma: application in studies of essential hypertension. Br Med J (Clin Res Ed) 1983 Sep 3;287(6393):631–634. doi: 10.1136/bmj.287.6393.631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Erwteman T. M., Nagelkerke N., Lubsen J., Koster M., Dunning A. J. Beta blockade, diuretics, and salt restriction for the management of mild hypertension: a randomised double blind trial. Br Med J (Clin Res Ed) 1984 Aug 18;289(6442):406–409. doi: 10.1136/bmj.289.6442.406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. GROLLMAN A., GROLLMAN E. F. The teratogenic induction of hypertension. J Clin Invest. 1962 Apr;41:710–714. doi: 10.1172/JCI104529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Guthrie G. P., Jr Effects of digoxin on responsiveness to the pressor actions of angiotensin and norepinephrine in man. J Clin Endocrinol Metab. 1984 Jan;58(1):76–80. doi: 10.1210/jcem-58-1-76. [DOI] [PubMed] [Google Scholar]
  12. Haddy F. J. Mechanism, prevention and therapy of sodium-dependent hypertension. Am J Med. 1980 Nov;69(5):746–758. doi: 10.1016/0002-9343(80)90445-3. [DOI] [PubMed] [Google Scholar]
  13. Haddy F. J., Overbeck H. W. The role of humoral agents in volume expanded hypertension. Life Sci. 1976 Oct 1;19(7):935–947. doi: 10.1016/0024-3205(76)90284-8. [DOI] [PubMed] [Google Scholar]
  14. Hamlyn J. M., Ringel R., Schaeffer J., Levinson P. D., Hamilton B. P., Kowarski A. A., Blaustein M. P. A circulating inhibitor of (Na+ + K+)ATPase associated with essential hypertension. Nature. 1982 Dec 16;300(5893):650–652. doi: 10.1038/300650a0. [DOI] [PubMed] [Google Scholar]
  15. Joossens J. V., Geboers J. Salt and hypertension. Prev Med. 1983 Jan;12(1):53–59. doi: 10.1016/0091-7435(83)90171-8. [DOI] [PubMed] [Google Scholar]
  16. MacGregor G. A. Dietary sodium and potassium intake and blood pressure. Lancet. 1983 Apr 2;1(8327):750–753. doi: 10.1016/s0140-6736(83)92036-6. [DOI] [PubMed] [Google Scholar]
  17. MacGregor G. A., Fenton S., Alaghband-Zadeh J., Markandu N., Roulston J. E., de Wardener H. E. Evidence for a raised concentration of a circulating sodium transport inhibitor in essential hypertension. Br Med J (Clin Res Ed) 1981 Nov 21;283(6303):1355–1357. doi: 10.1136/bmj.283.6303.1355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. MacGregor G. A., Markandu N. D., Best F. E., Elder D. M., Cam J. M., Sagnella G. A., Squires M. Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet. 1982 Feb 13;1(8268):351–355. doi: 10.1016/s0140-6736(82)91389-7. [DOI] [PubMed] [Google Scholar]
  19. Morgan T., Adam W., Gillies A., Wilson M., Morgan G., Carney S. Hypertension treated by salt restriction. Lancet. 1978 Feb 4;1(8058):227–230. doi: 10.1016/s0140-6736(78)90479-8. [DOI] [PubMed] [Google Scholar]
  20. Parijs J., Joossens J. V., Van der Linden L., Verstreken G., Amery A. K. Moderate sodium restriction and diuretics in the treatment of hypertension. Am Heart J. 1973 Jan;85(1):22–34. doi: 10.1016/0002-8703(73)90522-x. [DOI] [PubMed] [Google Scholar]
  21. Poston L., Sewell R. B., Wilkinson S. P., Richardson P. J., Williams R., Clarkson E. M., MacGregor G. A., de Wardener H. E. Evidence for a circulating sodium transport inhibitor in essential hypertension. Br Med J (Clin Res Ed) 1981 Mar 14;282(6267):847–849. doi: 10.1136/bmj.282.6267.847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Simpson F. O. Salt and hypertension: current data, attitudes, and policies. J Cardiovasc Pharmacol. 1984;6 (Suppl 1):S4–S9. [PubMed] [Google Scholar]
  23. WATKIN D. M., FROEB H. G., HATCH F. T., GUTMAN A. B. Effects of diet in essential hypertension. II. Results with unmodified Kempner rice diet in 50 hospitalized patients. Am J Med. 1950 Oct;9(4):441–493. doi: 10.1016/0002-9343(50)90200-2. [DOI] [PubMed] [Google Scholar]
  24. Yamori Y., Kihara M., Nara Y., Ohtaka M., Horie R., Tsunematsu T., Note S. Hypertension and diet: multiple regression analysis in a Japanese farming community. Lancet. 1981 May 30;1(8231):1204–1205. doi: 10.1016/s0140-6736(81)92363-1. [DOI] [PubMed] [Google Scholar]
  25. de Wardener H. E., MacGregor G. A. The relation of a circulating sodium transport inhibitor (the natriuretic hormone?) to hypertension. Medicine (Baltimore) 1983 Sep;62(5):310–326. doi: 10.1097/00005792-198309000-00004. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES